| Identification | Back Directory | [Name]
6-AZAURIDINE 2',3',5'-TRIACETATE | [CAS]
2169-64-4 | [Synonyms]
cb304
ta-azur
AZARIBINE
nsc-67239
6-AZURD-TA
triacetyl-6-azauridine
2’,3’,5’-triacetyl-6-azauridine
6-AZAURIDINE 2',3',5'-TRIACETATE
2',3',5'-TRI-O-ACETYL-6-AZAURIDINE
6-Azauridine 2',3',5'-triacetate,98%
(-)-6-AZAURIDINE 2',3',5'-TRIACETATE
6-Azauridine 2μ,3μ,5μ-triacetate, 6-AzUrd-TA, Azaribine
2-BETA-D-RIBOFURANOSYL-AS-TRIAZINE-3,5(2H,4H)-DIONE 2',3',5'-TRIACETATE
4h)-dione,2-(2’,3’,5’-triacetyl-beta-d-ribofuranosyl)-as-triazine-5-(2h
2-(2’,3’,5’-triacetyl-beta-d-ribofuranosyl)-as-triazine-3,5-(2h,4h)-dione
2-BETA-D-RIBOFURANOSYL-1,2,4-TRIAZINE-3,5(2H,4H)-DIONE 2',3',5'-TRIACETATE
2-(2-O,3-O,5-O-Triacetyl-β-D-ribofuranosyl)-1,2,4-triazine-3,5(2H,4H)-dione
2μ,3μ,5μ-Tri-O-acetyl-6-azauridine, 6-Azauridine 2μ,3μ,5μ-triacetate, 6-AzUrd-TA, Azaribine, 2-β-D-Ribofuranosyl-1,2,4-triazine-3,5(2H,4H)-dione 2μ,3μ,5μ-triacetate | [EINECS(EC#)]
218-515-6 | [Molecular Formula]
C14H17N3O9 | [MDL Number]
MFCD00006471 | [MOL File]
2169-64-4.mol | [Molecular Weight]
371.3 |
| Chemical Properties | Back Directory | [Appearance]
white to off-white powder or crystals | [Melting point ]
99-101 °C(lit.)
| [Boiling point ]
501.01°C (rough estimate) | [density ]
1.3535 (rough estimate) | [refractive index ]
1.5700 (estimate) | [storage temp. ]
Hygroscopic, -20°C Freezer, Under inert atmosphere | [solubility ]
Chloroform (Slightly), Methanol (Slightly) | [form ]
Solid | [color ]
White to Light Yellow | [Stability:]
Hygroscopic |
| Hazard Information | Back Directory | [Chemical Properties]
white to off-white powder or crystals | [Definition]
ChEBI: A N-glycosyl-1,2,4-triazine that is 6-azauridine acetylated at positions 2', 3' and 5' on the sugar ring. It is a prodrug for 6-azauridine and is used for treatment of psoriasis. | [Uses]
Antipsoriatic. | [Brand name]
Triazure (Parke-Davis);Cb 304;Ribo-azauracil. | [World Health Organization (WHO)]
Azaribine, an antineoplastic agent, was introduced in 1975 for the
treatment of severe, recalcitrant, disabling arthritis. Following reports of
thromboembolic and thrombotic reactions, the drug was withdrawn in the USA in
1976. The causal relationship between azaribine and these events has been
questioned and the drug remains available in the USA for investigational purposes. |
|
| Company Name: |
T&W GROUP
|
| Telephone: |
021-61551611 13296011611 |
| Website: |
www.trustwe.com/ |
| Company Name: |
NewCan Biotech Limited
|
| Telephone: |
+86-571-86912261 19975279805 |
| Website: |
https://www.newcanbio.com/ |
|